• Latest Posts

Discovery could lead to cancer drugs with fewer side effects

Sofinnova Partners dives into digital medicine, funds new companies

Ablaze Pharmaceuticals to develop first-in-class therapy for liver cancer in China

Destiny Pharma gel reduces nasal staph in surgery patients  

Candidate found to inhibit malignant melanoma growth

€260M fund addresses dementia investment shortfall

ADVERTISEMENT

Vaccitech announces positive topline data for chronic hepatitis study

Pharming immunodeficiency drug given FDA approval

ADVERTISEMENT